320: Jim Wilson's next venture, a surprise startup shutdown, & Lilly's Zepbound strategy
The Readout Loud
00:00
Navigating Biotech's Evolving Landscape
This chapter reflects on the current state of the biotech industry, examining the influences of economic conditions and the excitement surrounding obesity treatments. The discussion also considers the volatility in the market and the implications of recent developments on investor sentiment and stock performance.
Transcript
Play full episode
